Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Cost-effectiveness analysis of sunitinib in patients with metastatic and/or unresectable gastrointestinal stroma tumours (GIST) after progression or intolerance with imatinib

PaperCitations, authors & open-access status

Cost-effectiveness analysis of sunitinib in patients with metastatic and/or unresectable gastrointestinal stroma tumours (GIST) after progression or intolerance with imatinib is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 27 citations, 2008 year and closed oa status.

27
Citations
2008
Year
closed
OA Status

Related on ScholarIQ

Silvia Díaz‐Cerezo
Author
Gastrointestinal Tumor Research and Treatment
Topic
Gastrointestinal Tumor Research and Treatment
Topic
Gastric Cancer Management and Outcomes
Topic
Sarcoma Diagnosis and Treatment
Topic
470M+ articles · free account